SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Vir Biotechnology appointed Timothy Coughlin, CPA, as a new Class III…

Vir Biotechnology, Inc. · 8-K filed Jun 10, 2026 at 16:27 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 10, 2026 at 16:27 ET

Vir Biotechnology appointed Timothy Coughlin, CPA, as a new Class III director and Audit Committee Chair, expanding the board from 7 to 8 members. This is a routine governance change with no financial impact or strategic implications disclosed.

  • Board expanded from 7 to 8 members; Timothy Coughlin appointed to fill new vacancy
  • Coughlin will serve as Class III director until 2028 annual meeting and as Audit Committee Chair
  • No arrangement or understanding with any person triggered the appointment; no related party transactions
  • Coughlin receives standard non-employee director compensation per existing policy, including stock option and RSU grants under the 2019 Equity Incentive Plan

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access